Navigation Links
New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes

This condition should be corrected prior to administration of MICARDIS tablets, and treatment should start under close medical supervision.

The most common adverse events occurring with MICARDIS tablets monotherapy at a rate of 1% and greater than placebo, respectively, were: upper respiratory tract infection (URTI) (7%, 6%), back pain (3%, 1%), sinusitis (3%, 2%), diarrhea (3%, 2%), and pharyngitis (1%, 0%). Post-market adverse reactions include bradycardia, eosinophilia, thrombocytopenia, uric acid increase, abnormal hepatic function/liver disorder and renal impairment including acute renal failure, anemia and increased creatine phosphokinase.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2006, Boehringer Ingelheim posted net sales of US $13.3 billion (10.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

    For more information, please visit http://us.boehringer-ingelheim.com.


    References


    (1) Burgess E et al. Efficacy of telmisartan compared with losartan in

        reducing proteinuria in hypertensive type 2 diabetic patients with

        overt nephropathy. Presented at the Annual Meeting of the European
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
Post Your Comments:
(Date:11/18/2014)... 2014  Sanguine Biosciences – a biotechnology company ... recruitment – will use its proprietary mobile application ... Inc. find and recruit people diagnosed with Congenital ... to participate in voluntary research, which will be ... hopefully aid in informing the development of potential ...
(Date:11/18/2014)... and SAN DIEGO , ... HPPI), a clinical stage biopharmaceutical company that discovers, ... patients with cancer, announced today that it filed ... U.S. Food and Drug Administration (FDA) on Friday, ... covers HPPI,s proposed clinical development of a patented ...
(Date:11/18/2014)... 18, 2014  TransCelerate BioPharma Inc. ("TransCelerate") ... manuscript on Risk-Based Monitoring (RBM), " Evaluating ... Measure in Clinical Trials ," in the ... Regulatory Science  (TIRS) journal. Developed by TransCelerate,s ... the manuscript examines the value of Source ...
Breaking Medicine Technology:Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2HedgePath Pharmaceuticals Files IND Application 2HedgePath Pharmaceuticals Files IND Application 3HedgePath Pharmaceuticals Files IND Application 4TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3
... , , ... company leading the scientific research of neurogenesis using its proprietary ... central nervous system (CNS) diseases, announced today results from the ... dose buspirone and melatonin, for the treatment of major depressive ...
... , , HOUSTON, July ... the U.S. Food and Drug Administration ("FDA") has approved the company,s proposal ... patients treated with VNS Therapy(TM). , , ... of study subjects from 460 to 330 and completed enrollment of 331 ...
Cached Medicine Technology:Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 2Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 3Cyberonics Provides Update on Depression Post-Approval Study 2Cyberonics Provides Update on Depression Post-Approval Study 3
(Date:11/18/2014)... As children head back to school and ... fall as the perfect time to refresh their looks ... County facial plastic surgeon, has observed a trend this ... Gallery of Cosmetic Surgery he has noticed an increase ... surgery procedures. , “Non-invasive cosmetic treatments give my ...
(Date:11/18/2014)... 2014 (HealthDay News) -- Hispanic women who,ve had at least ... type of heart trouble than those who,ve had fewer children ... researchers led by Shivani Aggarwal of Wake Forest School of ... from Chicago, Miami, New York City and San Diego. About ... six children. A type of heart trouble called ventricular ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... attack and stroke patients can safely take aspirin combined with ... combination won,t increase a patient,s risk of early death, according ... of the American Heart Association in Chicago. The report was ... Analysis of data from more than a dozen clinical ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. 17, ... that help them track how many calories they consume each ... a popular one after their doctor recommended it did not ... idea of using such apps as weight-loss tools. Some participants ... of motivation varied, the researchers noted, and they added that ...
(Date:11/17/2014)... World Food Processing announced today that they will ... airing via RFD-TV 2nd QTR 2015. American Farmer airs ... World Food Processing is a sustainable solution for non-GMO ... provides a secure system, supplying non-GMO and organic products ... educate viewers about World Food Processing’s unparalleled capability to ...
Breaking Medicine News(10 mins):Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:American Farmer to Feature World Food Processing in 2015 Series 2
... WASHINGTON, July 1 Beginning July 6, Sharing,Miracles -- ... and inspirational stories of real patients -- will feature,four-time ... the,program will debut in Los Angeles on KCOP-TV at ... across the United States., Diver Greg Louganis won ...
... Accenx Technologies,Inc., is the premier sponsor of ... to Interoperability. The two-day event, held in Boston, ... Information Exchange (HIE) to the,next level., Accenx ... offering a Software as a Service (SaaS) solution ...
... health policy and administration in Penn State,s College of ... $4 million grant from the Robert Wood Johnson Foundation ... initiative, "Aligning Forces for Quality (AF4Q).", This grant is ... Robert Wood Johnson Foundation in 2007 and expands the ...
... Senetek PLC (OTC,Bulletin Board: SNKTY), a Life ... target the science of healthy aging, today announced,that ... with Triax,Aesthetics LLC for Pyratine-6(TM), all promotion, sales ... directly by the Company., Phil Rose, Senetek,s ...
... Glenn Hackbarth (MedPAC) and Bruce Bradley (General,Motors) - ... 1 The ABIM Foundation,will dedicate its efforts ... concepts,of medical professionalism and accountability in health care ... In addition, the Foundation announced that officers of ...
... Opus Healthcare Solutions, Inc.,a leading national ... Ray,Bechtold, CPA, as controller. Based at the ... overseeing all accounting and financial,administrative functions., ... http://www.newscom.com/cgi-bin/prnh/20080325/LATU040LOGO ), Bechtold joined Opus Healthcare ...
Cached Medicine News:Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 2Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 3Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 4Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 5Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 6Health News:Accenx Technologies, a Premier Sponsor as the Educational Underwriters of the 3rd Annual World Congress Leadership Summit on The Road to Interoperability 2Health News:Researcher receives $4 million from RWJ Foundation to study health quality reform project 2Health News:Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM) 2Health News:ABIM Foundation Announces New Focus and Governance 2Health News:ABIM Foundation Announces New Focus and Governance 3Health News:Opus Healthcare Solutions Names Ray Bechtold as Controller 2
LASIK Retreatment Forceps - Also available in Titanium...
To enter, dissect, elevate and smooth the flap. Combined features of Spatula, Dissector and Forceps. - Also available in Titanium...
The CGPL capsulotomy contact glass was designed by Riquin, Fankhauser et al. for the dissection of opacified posterior lens capsules and membranes in the pupillary and retropupillary space with the Y...
The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
Medicine Products: